SYRE Stock Posts

SYRE Spyre Therapeutics99.27+3.76+3.9%

After Hours:95.00-4.27 (-4.3%)

Spyre Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Globe NewswireTue, 3-Nov 4:01 PM

SYRE Spyre Therapeutics92.70-0.49-0.5%

After Hours:90.00-2.70 (-2.9%)

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

Globe NewswireMon, 5-Oct 4:01 PM

SYRE Spyre Therapeutics107.36+0.71+0.7%

Premarket:92.00-15.36 (-14.3%)

Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-study of the SKYWAY Phase 2 Trial of SPY072

Globe NewswireTue, 25-Aug 4:01 PM

SYRE Spyre Therapeutics63.27+11.98+23.4%

After Hours:62.35-0.92 (-1.5%)

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

Globe NewswireMon, 13-Apr 4:46 PM